|
Rivera-Caravaca JM, Lip GYH, Roldan V, Marin F. Editorial: New horizons in the management of patients with atrial fibrillation: Interactions with the gastrointestinal system. Front Cardiovasc Med. 2022 Oct 17;9:1042728. doi: 10.3389/fcvm.2022.1042728. eCollection 2022. No abstract available. PubMed PMID: 36324744; PubMed Central PMCID: PMC9619039.
AÑO: 2022; IF: 3.6
|
36324744
|
Esteve-Pastor MA, Rivera-Caravaca JM, Roldan V, Sanmartin Fernandez M, Arribas F, Masjuan J, Barrios V, Cosin-Sales J, Freixa-Pamias R, Recalde E, Perez-Cabeza AI, Manuel Vazquez Rodriguez J, Rafols Priu C, Anguita Sanchez M, Lip GYH, Marin F. Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry. Eur Heart J Cardiovasc Pharmacother. 2022 Dec 15;9(1):38-46. doi: 10.1093/ehjcvp/pvac060. PubMed PMID: 36318457.
AÑO: 2022; IF: 7.1
|
|
Gent DG, Rivera-Caravaca JM, Dobson R, Wright DJ, Lip GYH; Liverpool Centre for Cardiovascular Science. Ibrutinib use and adverse cardiovascular outcomes: A United States federated electronic medical records analysis. Eur J Intern Med. 2023 Feb;108:117-119. doi: 10.1016/j.ejim.2022.09.016. Epub 2022 Sep 24. No abstract available. PubMed PMID: 36163123.
AÑO: 2023; IF: 5.9
|
|
Castellano JM, Pocock SJ, Bhatt DL, Quesada AJ, Owen R, Fernandez-Ortiz A, Sanchez PL, Marin Ortuno F, Vazquez Rodriguez JM, Domingo-Fernandez A, Lozano I, Roncaglioni MC, Baviera M, Foresta A, Ojeda-Fernandez L, Colivicchi F, Di Fusco SA, Doehner W, Meyer A, Schiele F, Ecarnot F, Linhart A, Lubanda JC, Barczi G, Merkely B, Ponikowski P, Kasprzak M, Fernandez Alvira JM, Andres V, Bueno H, Collier T, Van de Werf F, Perel P, Rodriguez-Manero M, Alonso Garcia A, Proietti M, Schoos MM, Simon T, Fernandez Ferro J, Lopez N, Beghi E, Bejot Y, Vivas D, Cordero A, Ibanez B, Fuster V; SECURE Investigators. Polypill Strategy in Secondary Cardiovascular Prevention. N Engl J Med. 2022 Sep 15;387(11):967-977. doi: 10.1056/NEJMoa2208275. Epub 2022 Aug 26. PubMed PMID: 36018037.
AÑO: 2022; IF: 158.5
|
|
Esteve-Pastor MA, Rivera-Caravaca JM, Ruiz-Ortiz M, Muniz J, Roldan-Rabadan I, Otero D, Lopez-Galvez R, Cequier A, Bertomeu-Martinez V, Badimon L, Anguita M, Lip GYH, Marin F; FANTASIIA investigators. A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry. Expert Opin Pharmacother. 2022 Aug;23(12):1457-1465. doi: 10.1080/14656566.2022.2109961. Epub 2022 Aug 12. PubMed PMID: 35924672.
AÑO: 2022; IF: 3.2
|